Page last updated: 2024-12-11

corymine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

corymine: RN given refers to (3beta,16R,17R)-isomer; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5379626
CHEMBL ID1997828
MeSH IDM0282787

Synonyms (11)

Synonym
corymine
nsc381080 ,
nsc-381080
6472-42-0
CHEMBL1997828
2,4(1h)-cyclo-3,4-secoakuammilan-16-carboxylic acid, 3,17-epoxy-17-hydroxy-1-methyl-, methyl ester, (3.beta.,16r)-
KRTMWLRPHKYUJX-PQMHYQBVSA-N
corymin
13h-1,3,8a-(epoxyethanylylidene)-1h-azepino[1',2':1,2]pyrrolo[2,3-b]indole, 2,4(1h)-cyclo-3,4-secoakuammilan-16-carboxylic acid deriv.
2,4(1h)-cyclo-3,4-secoakuammilan-16-carboxylic acid, 3,17-epoxy-17-hydroxy-1-methyl-, methyl ester, (3.alpha.,16r,17r)-
methyl (15e)-15-ethylidene-18-hydroxy-3-methyl-19-oxa-3,13-diazahexacyclo[14.3.1.02,10.02,13.04,9.010,17]icosa-4,6,8-triene-17-carboxylate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]